Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Spallarossa

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|May 13, 2023
Amino-Pyrazoles in Medicinal Chemistry: A ReviewMatteo Lusardi, Andrea Spallarossa, Chiara Brullo
Nanomaterials (Basel, Switzerland)|January 21, 2022
Successful Dendrimer and Liposome-Based Strategies to Solubilize an Antiproliferative Pyrazole Otherwise Not Clinically ApplicableSilvana Alfei, Andrea Spallarossa, Matteo Lusardi, et al.
Archiv Der Pharmazie|June 12, 2009
Parallel synthesis of O-phenoxyethyl and O-adamantyl N-acyl thiocarbamates endowed with antiproliferative activityAndrea Spallarossa, Sara Cesarini, Silvia Schenone, et al.
International Journal of Molecular Sciences|August 10, 2024
PDE4D: A Multipurpose Pharmacological TargetMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|June 10, 2006
A novel potent non-nucleoside reverse transcriptase inhibitor acylthiocarbamate derivative with extensive intramolecular pi-pi interactionsAngelo Mugnoli, Alberto Borassi, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|December 10, 2021
The Development of BTK Inhibitors: A Five-Year UpdateBruno Tasso, Andrea Spallarossa, Eleonora Russo, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Nanotechnology for Pediatric Retinoblastoma TherapyEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
International Journal of Molecular Sciences|July 24, 2021
Btk Inhibitors: A Medicinal Chemistry and Drug Delivery PerspectiveChiara Brullo, Carla Villa, Bruno Tasso, et al.
Journal of Molecular Modeling|January 21, 2009
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analysesElena Cichero, Sara Cesarini, Andrea Spallarossa, et al.
European Journal of Medicinal Chemistry|December 3, 2008
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analysesElena Cichero, Sara Cesarini, Paola Fossa, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|May 13, 2023
Amino-Pyrazoles in Medicinal Chemistry: A ReviewMatteo Lusardi, Andrea Spallarossa, Chiara Brullo
Nanomaterials (Basel, Switzerland)|January 21, 2022
Successful Dendrimer and Liposome-Based Strategies to Solubilize an Antiproliferative Pyrazole Otherwise Not Clinically ApplicableSilvana Alfei, Andrea Spallarossa, Matteo Lusardi, et al.
Archiv Der Pharmazie|June 12, 2009
Parallel synthesis of O-phenoxyethyl and O-adamantyl N-acyl thiocarbamates endowed with antiproliferative activityAndrea Spallarossa, Sara Cesarini, Silvia Schenone, et al.
International Journal of Molecular Sciences|August 10, 2024
PDE4D: A Multipurpose Pharmacological TargetMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|June 10, 2006
A novel potent non-nucleoside reverse transcriptase inhibitor acylthiocarbamate derivative with extensive intramolecular pi-pi interactionsAngelo Mugnoli, Alberto Borassi, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|December 10, 2021
The Development of BTK Inhibitors: A Five-Year UpdateBruno Tasso, Andrea Spallarossa, Eleonora Russo, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Nanotechnology for Pediatric Retinoblastoma TherapyEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
International Journal of Molecular Sciences|July 24, 2021
Btk Inhibitors: A Medicinal Chemistry and Drug Delivery PerspectiveChiara Brullo, Carla Villa, Bruno Tasso, et al.
Journal of Molecular Modeling|January 21, 2009
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analysesElena Cichero, Sara Cesarini, Andrea Spallarossa, et al.
European Journal of Medicinal Chemistry|December 3, 2008
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analysesElena Cichero, Sara Cesarini, Paola Fossa, et al.
Pageof 7